Similar to this, H3K18la upregulates the transcription factors Y-box binding protein 1 (YBX1) and Yin Yang 1 (YY1) in bladder cancer, promoting anlotinib resistance and ultimately cisplatin resistance (59). This evidence concerns the gene YBX1 and urinary bladder carcinoma.